NCT02828917View on ClinicalTrials.gov

MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR)

NACompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

August 30, 2022

Conditions
de Novo or Restenosis Lesions
Interventions
DEVICE

MedJ-01 Ridaforolimus Eluting Coronary Stent System

Trial Locations (1)

247-8533

Shonan Kamakura General, Kamakura

Sponsors

Lead Sponsor

Medinol Ltd.
All Listed Sponsors
lead

Medinol Ltd.

INDUSTRY

NCT02828917 - MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) | Biotech Hunter | Biotech Hunter